Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beshom Holdings BhdXKLS:7668 58 3-Year EBITDA Growth Rate is -18.60% as of Apr. 2026. GuruFocus rates XKLS:7668 with a GF Score™ of 58/100 and a GF Value™ of RM0.84 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 523 Healthcare Providers & Services companies, Beshom Holdings Bhd ranks worse than 87.76% on this metric.
During the past 12 months, Beshom Holdings Bhd's average EBITDA Per Share Growth Rate was -10.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -18.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -24.20% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -15.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Beshom Holdings Bhd was 52.20% per year. The lowest was -30.10% per year. And the median was -11.75% per year.
Beshom Holdings Bhd (XKLS:7668) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Beshom Holdings Bhd 3-Year EBITDA Growth Rate Related Terms
Beshom Holdings Bhd 3-Year EBITDA Growth Rate Competitor Comparison
For the Pharmaceutical Retailers subindustry, Beshom Holdings Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beshom Holdings Bhd 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beshom Holdings Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Beshom Holdings Bhd's 3-Year EBITDA Growth Rate falls into.
Beshom Holdings Bhd 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -18.60% mean?
Beshom Holdings Bhd (XKLS:7668) has a 3-Year EBITDA Growth Rate of -18.60% as of Apr. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Beshom Holdings Bhd and its competitors. According to the industry distribution chart, Beshom Holdings Bhd ranks #459 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 87.8%.
Is Beshom Holdings Bhd's 3-Year EBITDA Growth Rate too high?
Beshom Holdings Bhd's current 3-Year EBITDA Growth Rate is -18.60%. Based on the distribution chart, Beshom Holdings Bhd ranks #459 out of 523 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Beshom Holdings Bhd has a GF Score™ of 58/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beshom Holdings Bhd's 3-Year EBITDA Growth Rate compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Beshom Holdings Bhd ranks #459 out of 523 companies for 3-Year EBITDA Growth Rate. This places Beshom Holdings Bhd in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 9.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 9.90, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Beshom Holdings Bhd and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 9.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beshom Holdings Bhd's current 3-Year EBITDA Growth Rate is -18.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beshom Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Beshom Holdings Bhd (XKLS:7668) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.84, compared to a current price of RM0.54 — trading 35.7% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -18.60%. Beshom Holdings Bhd's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Beshom Holdings Bhd (XKLS:7668), the current 3-Year EBITDA Growth Rate is -18.60% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beshom Holdings Bhd (XKLS:7668) Overvalued in 2026?
Based on GuruFocus' analysis, Beshom Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.54 is trading 35.7% below its estimated GF Value™ of RM0.84.
GuruFocus considers Beshom Holdings Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:7668:
3-Year EBITDA Growth Rate: -18.60%
GF Value™: RM0.84 vs. price of RM0.54 (35.7% below fair value)
No single metric tells the full story. See the XKLS:7668 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beshom Holdings Bhd is involved in wholesale and retail, multi-level marketing, pharmaceutical manufacturing, and Chinese medicinal clinics. The company has retail chain stores and franchises, Multi-Level-Marketing branches, stockists and sales points, and GMP manufacturing plants across Malaysia. The product brands of the company include Health Food, Herbs, Medicated Tonic, medicine, wellness & Beauty, and others. The company has four reportable segments: Wholesale, Multi-level Marketing, Retail, and Investment holding. The company generates the majority of its revenue from the Investment holding segment.
58GF Score
Get the complete analysis for XKLS:7668
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7668 has been successfully added to your 
